[CRISPR-Cas system as molecular scissors for gene therapy].
Zeitschrift fur Rheumatologie, 76(1): 46-49 PMID 28124743 DOI 10.1007/s00393-017-0267-7
Abstract
Since the discovery of the CRISPR-Cas system as the adaptive immune system of prokaryotes, the underlying mechanism has proven to be a precise molecular tool for the targeted editing of genetic information in various cell types. By using the CRISPR-Cas9 system DNA sequences can be cut out at any site in the genome and changed in a sequence-specific manner. In the long term this provides the opportunity to cure diseases caused by gene mutations.